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Monoclonal antibodies which recognize different epi opes on either titin or nebulin show normal staining 
patterns on frozen sections of three muscle biopsies of Duchenne muscular dystrophy (DMD). Gel electro- 
phoresis and immunoblotting performed on two of these muscle biopsies show the normal pattern of titin 
and nebulin polypeptides. Since the donor of one of these biopsies has a large deletion of the Y-region of 
the DMD gene, our results argue against the recent proposal that nebulin is the gene mutated in DMD. 
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1. INTRODUCTION 
Duchenne muscular dystrophy (DMD) is an X- 
linked human disorder which occurs approximate- 
ly once in every 4000 live male births (reviews 
[1,2]). Kunkel, Monaco and colleagues have 
described the DMD gene and provided DNA 
probes useful for carrier and prenatal diagnosis. 
The transcript of the DMD gene is 16 kilobases in 
size and therefore unusally large [1,3]. Recently 
Wood et al. [4] reported that the nebulin band was 
either absent or extremely faint in polypeptide pat- 
terns from muscle biopsies of 30 DMD patients. 
Thus they proposed that nebulin might be the 
direct product of the DMD gene [4] and that the 
disease could affect a structural protein of the 
elastic component of skeletal muscle. This compo- 
nent is known from the work of Maruyama [5] and 
Wang [6] to contain two unusually large polypep- 
tides. The actual molecular masses of titin 
(1-3 MDa) and nebulin (0.5-0.8 MDa) are, 
however, not known exactly. 
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In the course of a study on the elastic component 
of the sarcomer begun 2 years ago [7] we have 
generated sets of monoclonal antibodies specific 
for either titin or nebulin from chicken. Immuno- 
electron-microscopical data to be reported else- 
where showed that the different antibodies in each 
set recognize different epitopes and that these 
epitopes are also present in human skeletal muscle 
(D.F., M.O., R.N. and K.W., in preparation). 
Here we have used these antibodies on muscle 
biopsies from DMD patients and reach a conclu- 
sion distinct from that of Wood et al. [4]. 
2. MATERIALS AND METHODS 
Biopsy I was from a 5-year-old boy. The 
diagnosis of DMD was based on clinical symptoms 
and characteristic morphological changes. Biopsy 
II was from a 7-year-old boy affected with DMD 
and was obtained from the femoral quadriceps 
muscle. Biopsy III was from a fetus diagnosed as 
affected with DMD and was obtained after abor- 
tion. Control muscle was represented by human leg 
striated muscle removed during surgery. 
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Biopsy material, previously frozen in liquid 
nitrogen and then stored at -80°C,  was 
homogenized in 5 mM Tris-HC1 (pH 7.4), 5 mM 
EGTA, 1 mM PMSF and 1 mM iodoacetamide us- 
ing a small glass-teflon homogenizer. 1 vol. of 
2-times concentrated sample buffer (25 mM Tris- 
HC1, pH 8.4, 2.5 mM EDTA, 20% glycerol, 3.0% 
2-mercaptoethanol, 10% SDS) prewarmed to 50°C 
was added per volume of homogenate. Samples 
were gently mixed, incubated at 50°C for 10 min 
and either immediately subjected to electro- 
phoresis or stored frozen at -20°C.  Electro° 
phoresis was performed on linear polyacrylamide 
gradient gels (2-12% acrylamide; 0.5% cross- 
linker) in the standard buffer system but omitting 
a stacking gel. Immunoblotting using hybridoma 
supernatants was as described [7]. Indirect im- 
munofluorescence microscopy on frozen muscle 
sections was performed after acetone fixation by 
standard procedures using the hybridoma super- 
natants and FITC-labeled sheep anti-mouse anti- 
bodies. 
Genomic DNA was extracted from peripheral 
blood, lymphoblastoid cell lines or, in the case of 
the affected fetus (biopsy III), from liver following 
established procedures [8]. After digestion with 
restriction enzymes the samples of genomic DNA 
were electrophoresed on 0.8% agarose, blotted 
and hybridized to 32p-labeled probes as in [9]. The 
probes used were kindly provided by Dr P. Pear- 
son (754), R. Worton (XJI.1), L. Kunkel (pERT), 
G.B. van Ommen (J-66) and J.L. Mandel (C7). 
Fig. 1. Immunofluorescence microscopy with nebulin and titin antibodies of control skeletal muscle and different DMD 
muscular dystrophy specimens. (a-c) Titin T3: (a,b) case I, (c) case III. These profiles are indistinguishable from those 
seen on normal human muscle (cf. [7]). (d-h) Nebulin: (d) normal human skeletal muscle, Nb6, (e) case I, Nb4, (f) case 
I, Nbl, (g) case Ill, Nb4, (h) case III, Nbl (cross-section). Positive staining is seen in both the normal and the dystrophic 
samples. Magnification: (a-g) ×400, (h) ×680. 
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3. RESULTS 
Immunofluorescence microscopy was per- 
formed with 4 titin monoclonal antibodies (T1, T3, 
T4, T12) and 6 nebulin monoclonal antibodies 
(Nbl, Nb2, Nb3, Nb4, Nb6, Nb7) on frozen sec- 
tions of three DMD specimens. Although not every 
antibody was used on each specimen all antibodies 
used gave normal striated staining patterns. Ex- 
amples are given in fig.1. Within the limits of the 
method neither the general appearance nor the in- 
tensity of labeling seemed different in DMD 
specimens when compared to normal human mus- 
cle. 
Since some DMD patients characteristically 
show deletions within the DMD gene [1] we also 
studied the polypeptide patterns een in total SDS 
extracts. For this analysis only biopsies II and III 
could be used as sufficient amounts of biopsy I 
were not available. Fig.2 shows that in both 
specimens titin and nebulin had apparent 
molecular masses equivalent to those found in con- 
trol samples of normal human skeletal muscle. 
Moreover, the relative amounts of the two proteins 
seemed similar in the DMD samples and the con- 
trols. In parallel experiments gels were analyzed by 
immunoblotting with monoclonal antibodies to 
assign unambiguously the titin and nebulin reac- 
tivities. This is documented for normal human 
muscle and DMD biopsy III in fig.2 and again 
shows that titin and nebulin display apparently 
normal molecular masses. Significant proteolytic 
breakdown of nebulin is not seen, probably 
because iodoacetamide was included in the 
homogenization solution. This compound is 
known to inhibit thiol proteases including the in- 
tracellular CaZ+-dependent proteases (calpains). 
Degradation of titin was very limited (fig.2) and 
did not give rise to the 400 kDa fragment [5] which 
is recognized by our titin antibodies. 
The results of a detailed analysis carried out in 
the family of the aborted DMD fetus indicated the 
presence in the mother, in an affected son and in 
the same fetus of an extensive deletion of the DMD 
gene. This deletion does not include the locus 
DXS84 recognized by probe 754, and includes the 
region of the gene revealed by probes XJ 1.1, pERT 
87.1, 87.8, 87.15 but not hat revealed by J.66. Ac- 
cording to present knowledge [1] this deletion 
covers therefore at least 400 kb of the 5'-portion 
of the gene. Partial data on the analysis regarding 
the pERT region are shown in fig.3. The last two 
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Fig.2. Gel electrophoretic and immunoblot analysis of normal (a) and different DMD (b,c) human muscle samples. 
Lanes 1 show Coomassie blue-stained gel patterns of muscle samples. Lanes 2-8 (in a,b) show corresponding im- 
munoblots of the muscle samples with monoclonal ntibodies directed against titin (lanes 2,3) or nebulin (lanes 4-8). 
Titin antibodies were T3 (lanes 2) and T10 (lanes 3). Nebulin antibodies were Nbl (lane 4), Nb2 (lane 5), Nb3 (lane 
6), Nb4 (lane 7) and Nb6 (lane 8). Degradation of titin is minimal (see section 3). Note intactness of the nebulin polypep- 
tide in the DMD samples. Lanes bl and cl give results on DMD cases III and II, respectively. The positions of titin 
(T), nebulin (N) and myosin heavy chain (M) are marked on the left. Only the upper relevant part of gels and blots 
are shown. An unidentified polypeptide above myosin was only weakly present in normal muscle (a). 
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Fig.3. Results of Southern blotting after digestion with 
XmnI  and electrophoresis of genomic DNA from the in- 
dividual members of the family showing a deletion of the 
DMD gene (biopsy III). The radiolabeled probes pERT 
87.1 and 15 hybridized respectively to the following sets 
of fragments: 8.7 and 7.5 kb alleles revealed by pERT 
87.1 at the top, and 2.8 kb (common fragment) plus 1.6 
and 1.2 kb alleles revealed by pERT 87.15 at the bottom. 
Each lane corresponds to the genomic DNA of the in- 
dividuals indicated at the top of the figure as follows: 
(o) normal female; (0) carrier female (by CPK test); 
(n) normal male; (=) affected male; (I") aborted af- 
fected fetus. 
individuals on the right of this figure (affected liv- 
ing son and affected aborted fetus) do not show 
any signal with the pERT probes, while their 
mother is a carrier as indicated by her altered 
creatine phosphokinase (CPK) test. 
4. DISCUSSION 
Our results argue that nebulin and titin are 
readily detected in DMD specimens and the two 
DMD muscle biopsies studied by SDS gel analysis 
show no obvious differences when compared to 
normal human striated muscle. The further 
analysis of patient II I  and of his family using DNA 
probes is particularly important in that it showed 
that the 5'-portion of the DMD gene was deleted. 
Thus, it seems unlikely that either nebulin or titin 
represents he protein coded for by the DMD gene. 
After our results were completed we learned from 
Dr Maruyama that he and his colleagues had 
studied 2 preclinical DMD cases as well as 3 symp- 
tomatic DMD cases by gel electrophoresis and im- 
munoblotting using polyclonal antibodies to titin 
and nebulin [10]. While they noted some pro- 
teolytic degradation they could ascertain that 
nebulin was present in all cases. These authors did 
not report, however, any indication regarding the 
structure of the DMD gene in the patients they 
studied [10]. 
The two studies, which complement each other, 
yield results which differ from those of Wood et al. 
who reported that in 30 DMD patients the 
nebulin was "absent or extremely faint" [4]. Cur- 
rently it is difficult to account for the difference. 
While Maruyama's laboratory favours differential 
in situ proteolysis there is an additional possibility. 
Both we and Maruyama's group processed frozen 
biopsy material directly for SDS gel electro- 
phoresis while Wood et al. seem to have included 
an additional step involving the preparation of 
"myofibri l lar-sediments" [4]. Thus currently it 
cannot be excluded that proteolysis of DMD 
samples could have occurred at this stage and 
Wang [6] has already alluded to the difficulties in 
documenting nebulin in gel electrophoresis. 
The final identification of the protein coded for 
by the DMD gene should come from the isolation 
and sequence of the DMD gene. While it may still 
take some time to obtain limited amino acid se- 
quence data on nebulin, and to search for the 
presence of such sequences in the product 
predicted by the DNA sequence of the DMD gene, 
it seems unlikely on the basis of the present data 
that nebulin represents he DMD gene product. An 
additional consideration contributes to exclude the 
latter hypothesis. Titin and nebulin are major 
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myofibril lar proteins accounting for some 10°70 of 
the sarcomeric proteins [61 and therefore should 
arise from abundant mRNA species. The 
transcript corresponding to the DMD gene is in- 
stead scarcely represented in muscle cells [111, 
which is again in disagreement with the 'nebulin 
hypothesis'. 
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